Successful Montelukast Treatment in an Infant with Steroid-Resistant Eosinophilic Colitis

Eosinophilic colitis (EC) belongs to a group of idiopathic diseases called eosinophilic gastrointestinal disorders, which are characterized by eosinophil-predominant inflammation in the gastrointestinal tract. Corticosteroids is the first-line pharmacotherapy for EC refractory to diet therapy. We re...

Full description

Bibliographic Details
Main Authors: Nai-Wei Wang, Hsuan Hsieh, Yao-Jong Yang
Format: Article
Language:English
Published: Karger Publishers 2021-03-01
Series:Case Reports in Gastroenterology
Subjects:
Online Access:https://www.karger.com/Article/FullText/513146
_version_ 1831764340258111488
author Nai-Wei Wang
Hsuan Hsieh
Yao-Jong Yang
author_facet Nai-Wei Wang
Hsuan Hsieh
Yao-Jong Yang
author_sort Nai-Wei Wang
collection DOAJ
description Eosinophilic colitis (EC) belongs to a group of idiopathic diseases called eosinophilic gastrointestinal disorders, which are characterized by eosinophil-predominant inflammation in the gastrointestinal tract. Corticosteroids is the first-line pharmacotherapy for EC refractory to diet therapy. We report an infant with steroid-resistant EC, who successfully returned to a healthy growth trajectory under the combined therapy of montelukast and ketotifen. An 8-month-old boy presented with bloody diarrhea, anemia, and failure to thrive (FTT) that started 6 days after birth. The patient has no known allergies. A trial of elementary diet was unsuccessful. The results of several stool cultures were unremarkable. Similarly, lower gastrointestinal series failed to identify anything significant. At 3 months of age, an esophagogastroduodenoscopy with biopsies from the distal duodenum and proximal jejunum were unremarkable. The diarrhea and FTT persisted. A rectosigmoidoscopy with biopsies was performed; the results led to the diagnosis of EC at 5 months of age. Oral prednisolone 1 mg/kg/day was prescribed; however, 3 months into the treatment, persistent bloody diarrhea and FTT were still noted. Montelukast and ketotifen were added, after which diarrhea and weight gain started to improve. Prednisolone and montelukast/ketotifen were tapered off 6 months after. He remains symptom free and has normal growth and development in a 5-year follow-up.
first_indexed 2024-12-22T05:42:18Z
format Article
id doaj.art-d8933259a2e1430cacfa29656c9fb79d
institution Directory Open Access Journal
issn 1662-0631
language English
last_indexed 2024-12-22T05:42:18Z
publishDate 2021-03-01
publisher Karger Publishers
record_format Article
series Case Reports in Gastroenterology
spelling doaj.art-d8933259a2e1430cacfa29656c9fb79d2022-12-21T18:37:10ZengKarger PublishersCase Reports in Gastroenterology1662-06312021-03-0115138939410.1159/000513146513146Successful Montelukast Treatment in an Infant with Steroid-Resistant Eosinophilic ColitisNai-Wei Wang0Hsuan Hsieh1Yao-Jong Yang2Hull York Medical School, Allam Medical Building, University of Hull, Hull, United KingdomDepartment of Pediatrics, National Cheng Kung University Hospital, Medical College, National Cheng Kung University, Tainan, TaiwanDepartment of Pediatrics, National Cheng Kung University Hospital, Medical College, National Cheng Kung University, Tainan, TaiwanEosinophilic colitis (EC) belongs to a group of idiopathic diseases called eosinophilic gastrointestinal disorders, which are characterized by eosinophil-predominant inflammation in the gastrointestinal tract. Corticosteroids is the first-line pharmacotherapy for EC refractory to diet therapy. We report an infant with steroid-resistant EC, who successfully returned to a healthy growth trajectory under the combined therapy of montelukast and ketotifen. An 8-month-old boy presented with bloody diarrhea, anemia, and failure to thrive (FTT) that started 6 days after birth. The patient has no known allergies. A trial of elementary diet was unsuccessful. The results of several stool cultures were unremarkable. Similarly, lower gastrointestinal series failed to identify anything significant. At 3 months of age, an esophagogastroduodenoscopy with biopsies from the distal duodenum and proximal jejunum were unremarkable. The diarrhea and FTT persisted. A rectosigmoidoscopy with biopsies was performed; the results led to the diagnosis of EC at 5 months of age. Oral prednisolone 1 mg/kg/day was prescribed; however, 3 months into the treatment, persistent bloody diarrhea and FTT were still noted. Montelukast and ketotifen were added, after which diarrhea and weight gain started to improve. Prednisolone and montelukast/ketotifen were tapered off 6 months after. He remains symptom free and has normal growth and development in a 5-year follow-up.https://www.karger.com/Article/FullText/513146eosinophilic colitismontelukaststeroid-sparing therapydiarrhea
spellingShingle Nai-Wei Wang
Hsuan Hsieh
Yao-Jong Yang
Successful Montelukast Treatment in an Infant with Steroid-Resistant Eosinophilic Colitis
Case Reports in Gastroenterology
eosinophilic colitis
montelukast
steroid-sparing therapy
diarrhea
title Successful Montelukast Treatment in an Infant with Steroid-Resistant Eosinophilic Colitis
title_full Successful Montelukast Treatment in an Infant with Steroid-Resistant Eosinophilic Colitis
title_fullStr Successful Montelukast Treatment in an Infant with Steroid-Resistant Eosinophilic Colitis
title_full_unstemmed Successful Montelukast Treatment in an Infant with Steroid-Resistant Eosinophilic Colitis
title_short Successful Montelukast Treatment in an Infant with Steroid-Resistant Eosinophilic Colitis
title_sort successful montelukast treatment in an infant with steroid resistant eosinophilic colitis
topic eosinophilic colitis
montelukast
steroid-sparing therapy
diarrhea
url https://www.karger.com/Article/FullText/513146
work_keys_str_mv AT naiweiwang successfulmontelukasttreatmentinaninfantwithsteroidresistanteosinophiliccolitis
AT hsuanhsieh successfulmontelukasttreatmentinaninfantwithsteroidresistanteosinophiliccolitis
AT yaojongyang successfulmontelukasttreatmentinaninfantwithsteroidresistanteosinophiliccolitis